ORGANOGENESIS INC
3, 1999-10-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIRMINGHAM STEEL CORP, DEFA14A, 1999-10-14
Next: EATON VANCE INVESTMENT TRUST, 497, 1999-10-14



<PAGE>

                    U.S. SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

FORM 3                                                      OMB APPROVAL
                                                   -----------------------------
                                                   OMB NUMBER:  3235-0104
                                                   Expires:  September 30, 1998
                                                   Estimated average burden
                                                   hours per response ...... 0.5
                                                   -----------------------------


            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES



    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
      Section 17(a) of the Public Utility Holding Company Act of 1935 or
              Section 30(f) of the Investment Company Act of 1940




1. Name and Address of Reporting Person

LAUGHLIN                             PHILIP                             M.
- - --------------------------------------------------------------------------------
  (Last)                             (First)                         (Middle)

c/o Organogenesis Inc  150 Dan Road
- - --------------------------------------------------------------------------------
                                    (Street)

Canton                                 MA                             02021
- - --------------------------------------------------------------------------------
  (City)                             (State)                          (Zip)

October 4, 1999
- - --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)


- - --------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)

ORGANOGENESIS INC. (American Stock Exchange: "ORG")
- - --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol


- - --------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer:
       (Check all applicable)


             X    Director                         10% Owner
           -----                           ------

              X   Officer (give                    Other (Specify
           -----           title below)    ------         below)

                   President and Chief Operating Officer
                   -------------------------------------

- - --------------------------------------------------------------------------------
6. If Amendment, Date of Original   (Month/Day/Year)


- - --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)

            X    Form filed by One Reporting Person
          -----

                 Form filed by More than One Reporting Person
          -----

- - --------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                      Table 1 -- Non-Derivative Securities Beneficially Owned

1. Title of Security          2. Amount of Securities         3. Ownership Form:        4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                    Beneficially Owned              Direct (D) or             (Instr. 5)
                                 (Instr. 4)                      Indirect (I)
                                                                 (Instr. 5)
- - --------------------------    ---------------------------      -----------------        ------------------------------------------
<S>                           <C>                              <C>                      <C>

None
- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------

- - --------------------------    ---------------------------      -----------------        ------------------------------------------
</TABLE>

Reminder: Report on a separate line for each class of securities beneficially
          owned directly or indirectly.

 * If the form is filed by more than one reporting person, see Instruction
   5(b)(v).




                                                                         (Over)
                                                                SEC 1473 (7-96)
<PAGE>

FORM 3 (continued)

<TABLE>
<CAPTION>

        Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security   2. Date Exer-   3. Title and Amount of Securities  4. Conversion   5. Ownership    6. Nature of
                                     cisable and     Underlying Derivative Security     or Exercise     Form of         Indirect
                                     Expiration     (Instr. 4)                          Price of        Derivative      Beneficial
                                     Date                                               Derivative      Security:       Ownership
                                    (Month Day                                          Security        Direct (D)     (Instr. 5)
                                     Year)                                                              or
                                  ------- ------- ---------------------------------                     Indirect (I)
                                  Date    Expira-                            Amount                    (Instr. 5)
                                  Exer-   tion                               or
                                  cisable Date             Title             Number
                                                                             of
                                                                             Shares
- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------
<S>                               <C>     <C>     <C>                        <C>    <C>             <C>             <C>
Stock option***                   10/4/00 10/3/09  Common Stock              500,000  $6.875        D
- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------

- - -------------------------------   ------- -------  ------------------------  ------ --------------- --------------- -------------
</TABLE>
Explanation of Responses:

 + Consists of an option to purchase up to 500,000 shares of stock vesting in
   five equal annual installments commencing October 4, 2000. All or a portion
   of the option may be exercised earlier than the original vesting dates upon
   the occurrence of certain events, including certain events constituting a
   "change of control" or termination without cause of Mr. Laughlin's employment
   or termination of Mr. Laughlin's employment for "good reason", each as set
   forth in further detail in an employment letter dated October 4, 1999 between
   the Registrant and Mr. Laughlin.


** Intentional misstatements or omissions of fcats constitute Federal Criminal
   Violations.
   See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).




                              _______________________________    ______________
                              **Signature of Reporting Person         Date


Note: File three copies of this Form, one of which must be manually signed. If
      space provided is insufficient,
      See Instruction 6 for procedure.



Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.

                                                                          Page 2

                                                                 SEC 1473 (7-96)


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission